Gary Gustafson

Especialista sênior de sucesso do cliente do CAS

Bio

Drug Discovery

PPI inhibitors show promise in cancer trials

Small molecule PPI inhibitors are on the brink of improving cancer treatments
|Artigo
Emerging Science

Are covalent inhibitors the key to curing cancer?

CAS and Totus Medicines discuss how targeted covalent inhibitors are revolutionizing cancer treatments.
|Artigo